Published 15 hours ago • loading... • Updated 15 hours ago
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall ...
The suit says IPO documents overstated credit controls and model quality, while investors face an August 4 deadline to seek lead-plaintiff status.
Rosen Law Firm reminds investors of a pending class action lawsuit against GeneDx Holdings Corp. covering the April 16, 2025, through May 4, 2026, Class Period, with an August 3, 2026, lead plaintiff deadline.
The lawsuit alleges that GeneDx misrepresented the impact of its Fabric acquisition on company financials, failing to disclose significant problems with Fabric's viability that negatively affected the company's overall business operations.
GeneDx executives claimed, "There is room to run in terms of reducing COGS in the future by combining the best of capability between GeneDx and Fabric," statements the lawsuit contends were false.
Investors who purchased GeneDx stock during the Class Period may be entitled to compensation without out-of-pocket fees, and may retain counsel or remain absent class members until a class is certified.
Interested investors may contact Phillip Kim, Esq. at Rosen Law Firm, which has recovered billions of dollars for investors, to join the action or obtain further information regarding the litigation.